- American University of Beirut, Lebanon
Internship / Residency
- Emory University School of Medicine, Atlanta
- American Board of Internal Medicine
- American Board of Pulmonary Medicine
- American Board of Critical Care Medicine
- Fellow, American College of Chest Physicians
- Pulmonary & Critical Care - Emory University School of Medicine
- Interventional Pulmonology - Beth Israel Deaconess Medical Center, Harvard University, Boston
Dr. Rabih Bechara joined Cancer Treatment Centers of America® (CTCA), Atlanta, in January 2013. The interventional pulmonologist focuses on lung cancer, as well as other cancers, malignancies and growths that occur in the chest cavity.
Dr. Bechara is in charge of building the pulmonology division at our Atlanta hospital, which offers advanced endoscopic diagnostic and therapeutic approaches to treating patients with abnormal growth and malignancies in the chest cavity.
Procedures that Dr. Bechara performs include endoscopic ultrasonography, confocal microendoscopy, pleuroscopy, stent placement for airway stenosis, photodynamic therapy and fiducial marker placement, to name a few.
Dr. Bechara has been recognized as one of Castle Connolly's Top Doctors® in Atlanta Magazine from 2009 - 2016.
“My goal for my patients is for them to have a better quality of life,” says Dr. Bechara. “If they have a good quality of life and I can make them feel comfortable during treatment, then I’ll be happy.”
Dr. Bechara earned a medical degree from American University of Beirut in Lebanon. He then completed an internship and residency at Emory University School of Medicine in Atlanta, where he also finished a fellowship in pulmonary and critical care. He continued his education with an interventional pulmonology fellowship at Beth Israel Deaconess Medical Center at Harvard University in Boston.
Prior to joining CTCA®, Dr. Bechara founded and directed the interventional pulmonology program at Emory University School of Medicine. He has received board certification from the American Board of Internal Medicine, the American Board of Pulmonary Medicine and the American Board of Critical Medicine. He is a fellow of the American College of Chest Physicians.
Dr. Bechara serves as chairman of the American Lung Association of Georgia and sits on the association's Southeast Board of Directors. He is also chairman of Lung Force Georgia, a member of the American College of Chest Physicians, American Thoracic Society, and on the Board of Directors of the American Association of Bronchology and Interventional Pulmonology.
Dr. Bechara is on the editorial board of Journal of Allergy & Therapy and Current Respiratory Care Reports, and his work has been published in American Journal of Physiology: Lung Cellular and Molecular Physiology, American Journal of Respiratory and Critical Care Medicine, and Journal of Bronchology.
He has authored abstracts, teaching manuals and chapters for various books. Dr. Bechara has been invited to numerous national and international conferences, and has given lectures and seminars on various topics at Harvard University, Duke University and Ohio State University.
A strong supporter of research, Dr. Bechara has received grants and contracts for various projects. He plans to bring that focus to CTCA, with a specific interest in new endoscopic techniques for lung cancer. He is also a Professor of Medicine at Augusta University, Medical College of Georgia, and a Professor of Medicine at Morehouse School of Medicine.
Dr. Bechara is proud to be a Freemason, and believes strongly in charity work. He has been married for more than a decade to his wife Kellie, and they have two daughters: Mia and Sofa. In addition to speaking three languages—English, French and Arabic—Dr. Bechara plays soccer, and is currently learning how to play the piano.
Patient ratings and comments
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.